| pubmed-article:2982267 | pubmed:abstractText | A summary of the current recommendations for administration of Rh immune globulin after several reproductive events is presented. The risks of failure to administer Rh immune globulin after delivery or abortion, amniocentesis, and massive transplacental hemorrhage are described. | lld:pubmed |
